TIMI
TIMI or Thrombolysis in Myocardial Infarction is a clinical trial group funded by the National Heart, Lung, and Blood Institute to investigate the treatment of acute myocardial infarction. This group has conducted several large, multicenter trials that have led to changes in medical guidelines and practice.
History[edit]
The TIMI Study Group was established in 1984 at the Brigham and Women's Hospital, a teaching affiliate of Harvard Medical School, to conduct the original TIMI Trial. The group has since grown to include over 50 clinical research professionals and has conducted over 50 clinical trials involving more than 200,000 patients worldwide.
TIMI Score[edit]
The TIMI Score is a tool used by healthcare professionals to assess the risk of death and ischemic events in patients with unstable angina or non-ST elevation myocardial infarction. The score is based on seven variables, each of which is associated with an increased risk of adverse outcomes. The higher the TIMI Score, the greater the risk.
TIMI Trials[edit]
The TIMI Trials have investigated a variety of treatments for acute myocardial infarction, including thrombolytic therapy, antiplatelet therapy, anticoagulant therapy, and invasive strategies. The results of these trials have informed the development of guidelines for the treatment of acute myocardial infarction.
See Also[edit]
References[edit]
<references />
External Links[edit]
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian